V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320007019 | 320003739 | 1.75 | null | Curative (C) | 2017-01-25 | 2017-06-07 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | N | 320018500 | CAPECITABINE + CISPLATIN + STREPTOZOCIN |
| 320007020 | 320003741 | 1.6 | null | Palliative (P) | 2014-04-19 | 2014-06-08 | Bevacizumab+Carbo+Gemcitabine | N | N | 320018528 | CISPLATIN + GEMCITABINE |
| 320007021 | 320003749 | 1.66 | 56.3 | Adjuvant (A) | 2016-09-01 | 2016-09-01 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 320018722 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007022 | 320005709 | 1.68 | 53.6 | Palliative (P) | 2017-11-15 | 2017-12-11 | CAPECITABINE + OXALIPLATIN | N | N | 320018760 | ICON8B TRIAL |
| 320007023 | 320003755 | 1.59 | 72.8 | Palliative (P) | 2018-01-26 | 2018-11-25 | Docetaxel 75mg/m2 (21 day) | N | N | 320018796 | CISPLATIN + GEMCITABINE |
| 320007024 | 320007096 | 1.73 | 94 | Palliative (P) | 2013-08-14 | 2013-10-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320018820 | CARBOPLATIN + CETUXIMAB + FU |
| 320007025 | 320005715 | 0 | 74.4 | Palliative (P) | 2013-08-18 | 2013-09-01 | EMA | N | N | 320018895 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007026 | 320003763 | 1.79 | null | Palliative (P) | null | 2015-07-24 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 320018909 | CAPECITABINE + CARBOPLATIN |
| 320007027 | 320003769 | 1.72 | null | Adjuvant (A) | 2015-03-03 | 2015-03-24 | Enzalutamide | N | N | 320019003 | ENZALUTAMIDE |
| 320007028 | 320003773 | 1.8 | 72 | Adjuvant (A) | 2018-06-05 | 2018-06-30 | CETUXIMAB + OXALIPLATIN + MDG | N | N | 320019030 | CARBOPLATIN + RT |
| 320007029 | 320003775 | 1.7 | 78.7 | Palliative (P) | null | 2015-03-25 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 320019077 | DACARBAZINE |
| 320007030 | 320007101 | 1.68 | 76.4 | Curative (C) | 2015-03-09 | 2015-04-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 320019230 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007031 | 320003787 | 1.76 | 89 | Curative (C) | 2017-10-14 | 2017-10-17 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 320019266 | CISPLATIN + ETOPOSIDE |
| 320007032 | 320005733 | 1.67 | 123.8 | Adjuvant (A) | 2015-06-13 | 2015-06-21 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 320019296 | VAI |
| 320007033 | 320003793 | 1.7 | null | Curative (C) | 2014-06-22 | 2014-07-25 | IBRUTINIB | N | N | 320019304 | CISPLATIN + ETOPOSIDE |
| 320007035 | 320003797 | 1.7 | 81.2 | Palliative (P) | 2015-03-09 | 2015-03-09 | AFLIBERCEPT + FU + IRINOTECAN | Y | N | 320019357 | IMATINIB |
| 320007036 | 320003806 | 1.8 | 54 | Palliative (P) | 2017-08-22 | 2018-03-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 320019453 | TEMOZOLOMIDE |
| 320007037 | 320003809 | 1.73 | 78.4 | Palliative (P) | 2017-01-12 | 2017-02-18 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 320019455 | IRINOTECAN + VINCRISTINE |
| 320007038 | 320005744 | 1.81 | null | Palliative (P) | 2014-08-09 | 2014-08-09 | CAPECITABINE + CARBOPLATIN | N | N | 320019466 | ECX |
| 320007039 | 320003814 | 1.67 | null | Curative (C) | 2018-03-16 | 2018-04-18 | Temozolomide 200mg/m2 | 01 | N | 320019513 | RMS 2005 TRIAL |
| 320007040 | 320003816 | 1.63 | 75.2 | Palliative (P) | null | 2015-08-31 | Docetaxel 75mg/m2 (21 day) | null | null | 320019541 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320007041 | 320003823 | 1.65 | 85 | Palliative (P) | 2014-06-05 | 2015-08-17 | GEMCITABINE | N | N | 320019677 | PEMBROLIZUMAB |
| 320007042 | 320005752 | 1.67 | 69.7 | Palliative (P) | 2014-11-18 | 2015-01-16 | Bevacizumab+Carbo+Pacliaxel | N | N | 320019736 | IPILIMUMAB |
| 320007044 | 320003851 | 1.67 | 52.3 | Palliative (P) | 2014-12-18 | 2017-03-21 | Etoposide oral | 02 | Y | 320020277 | SUNITINIB |
| 320007045 | 320003854 | 1.78 | 79.1 | Adjuvant (A) | 2016-03-26 | 2016-07-11 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 320020281 | VEMURAFENIB |
| 320007046 | 320003859 | 1.48 | 81.1 | Palliative (P) | 2016-09-19 | 2018-03-01 | ICON8B TRIAL | N | N | 320020343 | VINBLASTINE |
| 320007047 | 320003865 | null | 78.7 | Adjuvant (A) | 2017-12-24 | 2018-01-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320020416 | DOCETAXEL |
| 320007048 | 320003869 | 1.6 | null | Disease modification (D) | 2014-08-22 | 2014-08-29 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 320020419 | CETUXIMAB + OXALIPLATIN + MDG |
| 320007049 | 320003872 | 1.68 | 78 | Palliative (P) | 2017-07-12 | 2017-10-04 | ICON8 TRIAL | 02 | Y | 320020438 | ICON8B TRIAL |
| 320007050 | 320003876 | null | 44.2 | Palliative (P) | 2018-06-03 | 2018-06-11 | Temozolomide 200mg/m2 | 2 | N | 320020549 | CISPLATIN + GEMCITABINE |
| 320007052 | 320003881 | 1.62 | 54.8 | Palliative (P) | 2015-03-24 | 2015-04-16 | Carboplatin + Etoposide IV 3 day | null | null | 320020652 | CARBOPLATIN + RT |
| 320007053 | 320003886 | null | 60 | Palliative (P) | 2014-03-22 | 2014-04-09 | TEMOZOLOMIDE | N | N | 320020709 | CARBOPLATIN + RT |
| 320007054 | 320003891 | 1.8 | 78 | Palliative (P) | 2016-05-25 | 2016-05-27 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 320020718 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320007055 | 320003894 | 1.66 | 136.2 | null | 2019-07-06 | 2019-07-08 | CNS GCT II Germinoma - Carbo Etop | 02 | N | 320020748 | TEMOZOLOMIDE |
| 320007056 | 320003896 | 1.76 | 87 | Palliative (P) | 2015-11-15 | 2015-11-17 | Carboplatin + Etoposide IV 3 day | 02 | N | 320020795 | CARBOPLATIN + RT |
| 320007058 | 320003901 | 1.62 | 67 | Adjuvant (A) | 2013-04-14 | 2013-05-04 | INOVATYON Trial | 2 | N | 320020976 | OLAPARIB |
| 320007059 | 320003907 | 1.78 | 69.1 | Palliative (P) | 2015-01-15 | 2015-01-17 | Carboplatin + Etoposide IV 3 day | 2 | N | 320021011 | BCG |
| 320007060 | 320005785 | 1.48 | 103 | Palliative (P) | 2018-08-29 | 2018-08-29 | STS Rhabdomyosarcoma RMS 2005 IVA | 2 | N | 320021098 | IVA |
| 320007061 | 320003918 | 1.64 | 65 | Curative (C) | 2016-06-03 | 2016-06-04 | Ipilimumab | 02 | N | 320022743 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007062 | 320003920 | 1.7 | 48 | Palliative (P) | 2014-12-19 | 2015-01-26 | Capecitabine (21days) + Carboplatin | N | N | 320022758 | TEMOZOLOMIDE |
| 320007063 | 320003923 | 1.87 | 63.7 | Palliative (P) | 2017-08-23 | 2017-08-25 | Docetaxel | N | N | 320022776 | CETUXIMAB + RT |
| 320007064 | 320003927 | 1.68 | 64.7 | Curative (C) | 2019-03-21 | 2019-03-25 | CARBOPLATIN + RT | N | N | 320022811 | DOCETAXEL |
| 320007065 | 320003929 | 1.74 | 93 | Palliative (P) | 2018-08-14 | 2018-09-17 | Docetaxel 75mg/m2 (21 day) | N | N | 320022821 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 320007066 | 320003938 | 1.59 | 66 | Palliative (P) | null | 2018-07-08 | Ipilimumab | null | null | 320022868 | CYCLOPHOSPHAMIDE |
| 320007067 | 320003940 | 1.51 | 60.6 | Palliative (P) | 2016-01-26 | 2016-02-09 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 320022881 | IRINOTECAN + MDG + PANITUMUMAB |
| 320007068 | 320005803 | 1.71 | null | Palliative (P) | 2018-05-27 | 2018-11-19 | CARBOPLATIN + ETOPOSIDE | Y | null | 320022903 | CISPLATIN + GEMCITABINE |
| 320007070 | 320003948 | 1.53 | 68 | Palliative (P) | null | 2015-07-15 | CISPLATIN + GEMCITABINE | null | null | 320023007 | GEMCITABINE + TIP |
| 320007071 | 320003951 | 1.7 | 87.5 | Palliative (P) | 2018-11-29 | 2018-12-06 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320023057 | CAPECITABINE + OXALIPLATIN |
| 320007072 | 320003959 | 1.83 | null | Adjuvant (A) | 2015-10-31 | 2015-11-07 | Carboplatin + Etoposide IV 3 day | 02 | N | 320023133 | CETUXIMAB + RT |
| 320007073 | 320003962 | 1.7 | 69.2 | null | 2013-08-12 | 2013-09-09 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 320023140 | CARBOPLATIN + ETOPOSIDE |